Kidney-limited TMA is common in patients with complement dysregulation
Kidney International · 2024-09 · 106 (3) · 536-537
DOI: 10.1016/j.kint.2024.06.009 ↗Kurz gefasst
Leserbrief in der Zeitschrift Kidney International, 2024-09. Verfasst von Daan P C van Doorn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Expert Center for Immune-mediated Kidney Diseases and Vasculitis, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Bi…. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Nierstichting.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Expert Center for Immune-mediated Kidney Diseases and Vasculitis, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht,…
Förderung
- Nierstichting
Zitieren
APA
van Doorn, D. P. C., van Paassen, P., Timmermans, S. A. M. E. G., & Limburg Renal Registry (2024). Kidney-limited TMA is common in patients with complement dysregulation. Kidney International, 106(3), 536-537. https://doi.org/10.1016/j.kint.2024.06.009
Vancouver
van Doorn DPC, van Paassen P, Timmermans SAMEG, Limburg Renal Registry. Kidney-limited TMA is common in patients with complement dysregulation. Kidney International. 2024;106(3):536-537. doi:10.1016/j.kint.2024.06.009
BibTeX
@article{vanDoorn2024,
author = {van Doorn, Daan P C and van Paassen, Pieter and Timmermans, Sjoerd A M E G and Limburg Renal Registry, Limburg Renal Registry},
title = {Kidney-limited TMA is common in patients with complement dysregulation},
journal = {Kidney International},
year = {2024},
volume = {106},
number = {3},
pages = {536--537},
doi = {10.1016/j.kint.2024.06.009}
}
EUVIMED